US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
Finberg et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofab56310
https://c19early.org/finberg.html